Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Rank in Stocks #23
Johnson & Johnson is a holding company, which engages in the research,... Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Share Price
$267.84
Market Cap
$645.47B
Change (1 day)
-0.63%
Change (1 year)
51.68%
Country
US
Trade Johnson & Johnson (JNJ)

Category

P/S ratio for Johnson & Johnson (JNJ)
P/S ratio as of September 2026 TTM: 6.55
According to Johnson & Johnson latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.55. At the end of 2024 the company had a P/S ratio of 3.88.
P/S ratio history for Johnson & Johnson from 2000 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
2026 (TTM) 6.55 22.73%
2025 5.34 37.35%
2024 3.88 -16.69%
2023 4.66 -18.58%
2022 5.73 14.81%
2021 4.99 7.02%
2019 4.66 10.68%
2018 4.21 -14.10%
2017 4.90 24.09%
2016 3.95 0.17%
2014 3.94 8.03%
2013 3.65 26.00%
2012 2.90 3.74%
2011 2.79 -3.16%
2010 2.88 12.44%
2008 2.57 -18.50%
2007 3.15 -13.52%
2006 3.64 -7.70%
2005 3.94 8.51%
2003 3.63 -18.22%
2002 4.44 -19.85%
2001 5.54 2.83%
2000 5.39 0.00%
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
13.45 105.22%
US
7.18 9.57%
US
4.66 -28.92%
CH
5.39 -17.80%
US
5.52 -15.77%
CH